Clinical Trial Update: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous tumor-infiltrating lymphocytes (GT101 Injection) for recurrent or metastatic cervical cancer; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• GT101 Injection (GT101)

Snippet

Sponsor: Grit Biotechnology | Conditions: Adult | Phase 2 | Status: RECRUITING